Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: a prospective multicenter study
Authors:
Open Access
- 17 November 2022
- journal article
- research article
- Published by Elsevier in Annals of Intensive Care
- Vol. 12 (1) , 1-10
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Practical Approach for Reliable Detection of AmpC Beta-Lactamase-Producing EnterobacteriaceaeJournal of Clinical Microbiology, 2011
- Comparison of Nine Phenotypic Methods for Detection of Extended-Spectrum β-Lactamase Production by EnterobacteriaceaeJournal of Clinical Microbiology, 2011
- AmpC β-LactamasesClinical Microbiology Reviews, 2009
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008
- Emergence of Antibiotic Resistance during Therapy for Infections Caused by Enterobacteriaceae Producing AmpC β-Lactamase: Implications for Antibiotic UseAntimicrobial Agents and Chemotherapy, 2008
- Bloodstream Infections Caused by Enterobacter Species: Predictors of 30-Day Mortality Rate and Impact of Broad-Spectrum Cephalosporin Resistance on OutcomeClinical Infectious Diseases, 2004
- Treatment of Ventilator‐Associated Pneumonia with Piperacillin‐Tazobactam/Amikacin Versus Ceftazidime/Amikacin: A Multicenter, Randomized Controlled TrialClinical Infectious Diseases, 1998
- The Relationship Between Antecedent Antibiotic Use and Resistance to Extended-Spectrum Cephalosporins in Group I -Lactamase-Producing OrganismsClinical Infectious Diseases, 1995
- Development of resistance byEnterobacter cloacae during therapy of pulmonary infections in intensive care patientsJournal of Molecular Medicine, 1994
- Effect of a Single Dose of Cefotaxime or Ceftriaxone on Human Faecal FloraDrugs, 1988